Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Celesta Capital | Deep Tech Venture Capital Firm. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Celesta Capital | Deep Tech Venture Capital Firm or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The Bio-Intelligence Revolution: Exploring the Intersection of High Tech & Biotech

50:03
 
Share
 

Manage episode 463658939 series 3642897
Content provided by Celesta Capital | Deep Tech Venture Capital Firm. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Celesta Capital | Deep Tech Venture Capital Firm or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Driven both by surging demand and rapid technology advancements, an emerging area of health innovation called “bioconvergence” is driving improvements in human health and sustained interest from investors. This episode will explore these new applications merging engineered technologies with scientific disciplines, including in diagnostics, therapeutics, and elsewhere.

Nobel Laureate Dr. Jim Rothman, Dr. Melanie Mathieu of Prellis Biologics, and Daniel Dornbusch of Excision join host Michael Marks for an in-depth discussion covering advancements in CRISPR technology, the role of AI in drug discovery, the future of personalized medicine, and much more.

  continue reading

21 episodes

Artwork
iconShare
 
Manage episode 463658939 series 3642897
Content provided by Celesta Capital | Deep Tech Venture Capital Firm. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Celesta Capital | Deep Tech Venture Capital Firm or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Driven both by surging demand and rapid technology advancements, an emerging area of health innovation called “bioconvergence” is driving improvements in human health and sustained interest from investors. This episode will explore these new applications merging engineered technologies with scientific disciplines, including in diagnostics, therapeutics, and elsewhere.

Nobel Laureate Dr. Jim Rothman, Dr. Melanie Mathieu of Prellis Biologics, and Daniel Dornbusch of Excision join host Michael Marks for an in-depth discussion covering advancements in CRISPR technology, the role of AI in drug discovery, the future of personalized medicine, and much more.

  continue reading

21 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play